Woodline Partners LP 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 2,114,056 2.400% | -2,226,284 (-51.29%) | Filing |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | Filing |